Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on May 22, 2024 1:40pm
81 Views
Post# 36052334

RE:RE:The evidence is clear

RE:RE:The evidence is clearoh how weak... since when is asking pertinent questions the same as bashing the stock..?

Many on this board appeart to think their are just two kinds of posters here... bashers and pumpers... 

The reality is obviously more nuanced than that... How can anyone not think that ONCY mgt has dithered, misdirected and made numerous misteps along the way... Where IS that Car-T deal???

Both Matt and Brad before him have over promised and underdelivered on every trial to date... The mBC IND-213 trial started in 2012... YES, 12 years ago... and it will be 13 years from the start of that trial before a Phase III will ever be running...

think that this will take 2-3 years to run, then 10 months for agency assessment, and you are then looking at approval by 2028-9.

GO back an listen to some of Matt's fireside chats about how they would be filing by 2023... yah right... so this isn't a bashing position but one of concern..

I believe in Pela, and used to have utmost faith in ONCY... but 20 years of delay, BS and lies by management have me holding at a loss... given the time I've been invested here, I will continue to hold... the ONLY inflection point I see is when they announce a partner to either buy them out, or pay for the 2 phase IIIs... and a partner will only engage if it's to enhance their own agent, i.e. a CPI, meaning that Bracelet-1 was a failure... ONCY are pratcially back where they were with mBC back in 2018, or is it 17.

Is it bashing to question the key patent expiring in 2027..?? or to ponder who's gonna pay for Phase III, or why senior leadership disappear from the company without let or hindrance... we all like to read positive posts on a stock we own, and hate those who question.... it's an affront to our investing wisdom right... But it's also smart to ask the questions that are uncomfortable... and invest in companies like this with no expectation of making any returns... 26 years and worth less than 100 million, whilst 10 year old CRSPR has multiple products, and is worth billions... time will tell... roll on the Type C meeting notes..!.

If the pumpers keep pumping, I'll keep on bringing some tempered reasoning back to the board... If you don't like, ignore...! 
 
<< Previous
Bullboard Posts
Next >>